ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,182.23
-0.11%
US Tech 100
17,646.20
0.19%
다우존스 지수
38,942.61
0.15%
Bitcoin
62,048.33
-0.46%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. OKYO Pharma Ltd (OKYO)

  7. OKYO Pharma Ltd (OKYO) 뉴스

OKYO OKYO Pharma Ltd

1.45
0.0258 (1.81%)
최종 업데이트: 23:52:53
15분 지연
기업명 주식 심볼 시장 주식 타입
OKYO Pharma Ltd OKYO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.0258 1.81% 1.45 23:52:53
개장가 저가 고가 종가 전일 종가
1.45 1.45 1.45 1.4242
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/05/202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/05/202420:00GLOBEOKYO Pharma Announces Participation in May 2024 Investor..
30/04/202420:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
09/04/202408:00GLOBEOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
02/04/202420:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
22/03/202420:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
21/03/202420:00GLOBEOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
20/03/202420:00GLOBEOKYO Pharma to Release New and Comprehensive Data from Phase..
09/02/202421:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
09/02/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/02/202421:00GLOBEOKYO Pharma Receives FDA Approval of IND for OK-101 in..
31/01/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/01/202421:00GLOBEOKYO Pharma Announces Distinguished Ophthalmologists with..
08/01/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202421:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05/01/202423:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202423:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
21/12/202321:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202307:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202306:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202321:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
29/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202305:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202305:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
31/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202320:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
10/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202300:34IHNWOKYO Pharma Announces Filing of an Investigational New Drug..
09/10/202320:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
05/10/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202320:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
16/09/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/09/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/09/202320:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
15/09/202319:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/09/202323:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/09/202323:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/09/202322:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
14/09/202321:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
14/09/202305:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/09/202305:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/09/202305:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
08/09/202320:04IHNWOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
08/09/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/09/202320:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
30/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/08/202320:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
29/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202320:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..

최근 히스토리

NASDAQ
OKYO
OKYO Pharma
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유